Rolandic Epilepsy Genomewide Association International Study

Completed

• Conditions: Rolandic Epilepsy
• Interventions: Other: Blood draw; Other: Existing samples

• Registration Number: NCT03547050
• Lead Sponsor: King's College London

Brief Summary

We have discovered a small change in the genetic code which increases the risk of the brainwave abnormality that is found in rolandic epilepsy. We now wish to confirm this using a second much larger sample of patients. We will investigate the other genetic changes that cause people with the brainwave abnormality to develop seizures, as well as problems with speech, coordination, attention and learning.

Detailed Description

Epilepsy is a common neurological disorder affecting 1% of the population. There are over 30 types of epilepsy, some common, some rare. Most epilepsies arise in childhood and have a genetic cause. Approximately 25% of child patients have "Rolandic Epilepsy" or RE, also known as Benign Epilepsy with Centrotemporal Spikes (BECTS). RE has a complex genetic basis, probably made up of combinations of susceptibility variants in different genes. Children with RE quite often have other symptoms that affect their speech, attention, reading ability or coordination. The goal of this study is to find the genetic basis for susceptibility to seizures and associated comorbidities for RE using genomewide association approaches.

We know that RE has a genetic basis and we recently discovered the genetic cause of the EEG pattern seen in RE. The goal of REGAIN is to now find the genetic basis for susceptibility to seizures and the associated symptoms above. Our hope is to be able to improve diagnosis and understand why each child with RE is different, and perhaps point us towards new treatments that are more effective and have fewer side effects.

We will compare the genetic code of 3,000 children with RE against a similar number of people not affected by epilepsy. With the proposed large sample of participants, we will be able to pinpoint the exact changes that might lead to seizures or attention problems for example. Learning the genetic basis for these problems will deepen our understanding of the mechanisms and lead to new treatments or cures.

Study Timeline

• Study First Submitted: 2018-05-24
• Study First Submitted QC: 2018-05-24
• Study Start: 2018-06-01
• Study First Posted: 2018-06-06
• Status Verified: 2023-03
• Primary Completion: 2023-03-17
• Study Completion: 2023-06-30
• Last Update Submitted: 2023-10-05
• Last Update Posted: 2023-10-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 210

Inclusion Criteria

1. Diagnosis of Rolandic Epilepsy in accordance with the following international criteria:

   • Age of first afebrile seizure 3-12 years
   • Seizures comprising focal sensorimotor seizures affecting the vocal tract and face, with or without involvement of the arm
   • Predominant sleep-related seizures
   • EEG interictal centro-temporal spikes with normal background

2. Current age 6-25 years

Exclusion Criteria

1. No history of focal seizure
2. Normal EEG or abnormal background features on EEG
3. Known structural causes (stroke, tuberous sclerosis, infection, post-infectious or metabolic)
4. Primary diagnosis of autism or global learning disability
5. Focal central neurological deficit on clinical exam,
6. Unable to provide informed consent
7. Unable to provide blood sample

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients diagnosed with RE	Blood draw	People who meet the eligibility requirements and have been diagnosed with rolandic epilepsy.
Controls	Existing samples	People without a lifetime history of seizures.

Primary Outcome Measures

Name	Time	Method
Allelic association p value corrected for genome wide testing	Day 1	We will look to see if there are changes in the genetic code that cause brainwave abnormalities close to the genetic changes that we have already discovered.

Trial Locations

Locations (13)

Dr. Juan P. Garrahan Children's Hospital; 🇦🇷 Buenos Aires, Argentina

King's College Hospital NHS Foundation Trust; 🇬🇧 London, United Kingdom

Hospital for Sick Kids; 🇨🇦 Toronto, Ontario, Canada

Hospital Mutua de Terrassa; 🇪🇸 Barcelona, Spain

Aghia Sophia Children's Hospital of Athens; 🇬🇷 Athens, Greece

Commissione Genetica Lega Italiana contro l'Epilepssia; 🇮🇹 Roma, Italy

Swansea University College of Medicine; 🇬🇧 Swansea, United Kingdom

Seattle Children's Hospital; 🇺🇸 Seattle, Washington, United States

Columbia University Medical Center; 🇺🇸 New York, New York, United States

Sicilian Epilepsy Network; 🇮🇹 Catania, Italy

Cardiff University School of Medicine; 🇬🇧 Cardiff, United Kingdom

Guy's and St Thomas' NHS Foundation Trust; 🇬🇧 London, United Kingdom

Hasbro Children's Hospital; 🇺🇸 Providence, Rhode Island, United States